ASA PHARMA PUBLIC LIMITED COMPANY

Asa Pharma Public Limited Company is a development-focused pharmaceutical firm dedicated to creating combination products for cardiovascular care. By designing innovative therapies and then out-licensing them to international pharmaceutical partners, Asa Pharma enables global manufacturers to handle marketing and sales while it concentrates on research, regulatory affairs and business development.

The company's flagship offering, Bisoprolol Acetylsalicylic-acid capsules, is already approved and commercially available across several EU and CIS markets. Building on this success, Asa Pharma is actively seeking additional licensing partners to expand the reach of this product throughout Europe and into export territories.

Leadership is provided by CEO Ann Donegan, who brings more than thirty years of experience across multinational organisations, local companies and start-up ventures. Under her guidance, Asa Pharma continues to specialise in cardiovascular combination therapies, delivering value to both partners and patients worldwide.